Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients

Miyakawa, Hiroshi; Matsushima, Hiroshi; Narita, Yoichi; Hankins, Raleigh W.; Kitazawa, Eriko; Fujikawa, Hirotoshi; Kikuchi, Kentaro; Matsushita, Masanao; Abe, Kazuhiro; Kawaguchi, Naomi; Morizane, Toshio; Kako, Makoto; Miyakawa, H; Matsushima, H; Narita, Y; Hankins, R W; Kitazawa, E; Fujikawa, H; Kikuchi, K; Matsushita, M
August 1998
Journal of Gastroenterology;1998, Vol. 33 Issue 4, p529
Academic Journal
journal article
Anti-liver-kidney microsome-1 (LKM-1), which reacts with cytochrome P450 IID6 (CYP2D6), is an autoantibody present in autoimmune hepatitis type II, which affects primarily young patients. Recently, it has been shown some adult patients with chronic hepatitis C are also positive for anti-LKM-1. Thus, anti-LKM-1-positive patients can be classified into two subgroups: (1) those with autoimmune hepatitis type II and (2) those with chronic hepatitis C. We investigated the antigenic epitopes of CYP2D6 with which each of these two anti-LKM-1-positive subgroups reacted. Multiple deletion mutants of CYP2D6 were constructed from a human liver cDNA library and five recombinant fusion proteins expressed. Antigenic epitopes were determined by immunoblot analysis using these proteins. Anti-LKM-1 present in HCV-negative sera recognized at least two peptide regions of aa213-280 and aa341-477 of human CYP2D6. In contrast, anti-LKM-1 present in HCV-positive sera recognized only a single region of aa341-477. Thus, the sera of patients with autoimmune hepatitis type II and patients with chronic hepatitis C recognize different antigenic epitopes of the CYP2D6 molecule. To our knowledge, this is the first time LKM-1 autoantigens have been analyzed at the molecular level in Japanese patients.


Related Articles

  • Diagnostic dilemmas in human immunodeficiency virus testing. Choudhary, Aashish; Gupta, Ekta; Kumar, Ramesh; Bajpai, Meenu; Sarin, Shiv // Asian Journal of Transfusion Science;Jul-Dec2014, Vol. 8 Issue 2, p145 

    A letter to the editor is presented which discusses a case study of a 64-year-old woman with a 10-year history of type 2 diabetes mellitus and underwent abnormal liver function tests (LFTs).

  • Association of HLA-DRB1 Alleles and Autoimmune Hepatitis in Turkish Patients.  // Medical Journal of Trakya University / Trakya Universitesi Tip F;2010, Vol. 27 Issue 3, p253 

    No abstract available.

  • Enzymes as Target Antigens of Liver-Specific Autoimmunity: The Case of Cytochromes P450s. Bogdanos, D. P.; Dalekos, G. N. // Current Medicinal Chemistry;2008, Vol. 15 Issue 22, p2285 

    Characterization of liver-specific autoantigens has given a fresh impetus to research in the pathogenesis of autoimmune liver diseases, viral-triggered and drug-induced autoimmunity affecting the liver. Intriguing is the fact that most of the liver-specific autoantigens are enzymes of key...

  • Autoimmune Hepatitis: A Review of Current Diagnosis and Treatment. Makol, Ashima; Watt, Kymberly D.; Chowdhary, Vaidehi R. // Hepatitis Research & Treatment;2011, p1 

    Autoimmune hepatitis (AIH) is a chronic inflammatory disorder characterized by periportal inflammation, elevated immunoglobulins, autoantibodies, and a dramatic response to immunosuppression. An environmental agent is hypothesized to trigger an immune-mediated attack directed against liver...

  • The Validity and Importance of Subtypes in Autoimmune Hepatitis: A Point of View. Czaja, Albert J.; Manns, Michael P. // American Journal of Gastroenterology;Aug1995, Vol. 90 Issue 8, p1206 

    Objective: To advocate formal subclassification of autoimmune hepatitis into two types based on the presence of mutually exclusive immunoserological markers, target antigen diversity, contrasting genetic predispositions, and differences in clinical profile and behavior. Methods: Relevant...

  • Genetic Distinctions between Types 1 and 2 Autoimmune Hepatitis. Czaja, Albert J.; Kruger, Martin; Santrach, Paula J.; Moore, S. Breanndan; Manns, Michael P. // American Journal of Gastroenterology;Dec1997, Vol. 92 Issue 12, p2197 

    Objectives: Our aim was to determine whether alleles affecting susceptibility to type 1 autoimmune hepatitis in the United States occur as commonly in German patients with type 2 disease. Methods: DNA specimens from 12 German patients with type 2 autoimmune hepatitis were tested for class II...

  • Genetic background of autoimmune hepatitis in Japan. Yoshizawa, Kaname; Umemura, Takeji; Ota, Masao // Journal of Gastroenterology;Jan2011, Vol. 46, p42 

    utoimmune hepatitis (AIH) is an organ-specific autoimmune disease characterized by chronic inflammation of the liver. Several studies from ethnically different countries have clarified that the genetic predisposition to type 1 AIH is linked mainly to human leukocyte antigen (HLA)-class II genes....

  • Diagnosis of Autoimmune Hepatitis using International Autoimmune Hepatitis Group Scoring. Priyantoro, Sigit Triyus; Achmad, Harijono // Indonesian Journal of Gastroenterology, Hepatology & Digestive E;Dec2013, Vol. 14 Issue 3, p185 

    Autoimmune hepatitis (AIH) is described as T lymphocyte suppressor disturbance, thus there is formation of autoantibody which attacks surface antigen of liver cells or hepatocytes. Diagnosis of AIH is done after other liver abnormalities have been ruled out. The diagnosis of AIH needs to be done...

  • Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. Zachou, Kalliopi; Rigopoulou, Eirini; Dalekos, George N. // Journal of Autoimmune Diseases (JAD);2004, Vol. 1, p2 

    Autoimmune hepatitis (AIH) is a chronic necroinflammatory disease of the liver characterized by hypergammaglobulinemia, characteristic autoantibodies, association with HLA DR3 or DR4 and a favorable response to immunosuppressive treatment. The etiology is unknown. The detection of non-organ and...

  • Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Baeres, M.; Herkel, J.; Czaja, A.J.; Wies, I.; Kanzler, S.; Cancado, E.L.R.; Porta, G.; Nishioka, M.; Simon, T.; Daehnrich, C.; Schlumberger, W.; Galle, P.R.; Lohse, A.W. // Gut;Aug2002, Vol. 51 Issue 2, p259 

    Background: Antibodies to soluble liver antigen/liver pancreas (SLA/LP) are specific markers of autoimmune hepatitis. Their target antigen has recently been cloned. Aims: To establish standardised immunoassays using the recombinant antigen, and to assess the frequency and significance of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics